Genmab EBIT 2019-2024 | GMAB

Genmab EBIT for the quarter ending September 30, 2024 was $0.310B, a 23.6% increase year-over-year.

  • Genmab 2023 EBIT was 0.773B, a 14.17% decline from 2022.
  • Genmab 2022 EBIT was 0.9B, a 87.47% increase from 2021.
  • Genmab 2021 EBIT was 0.48B, a 50.35% decline from 2020.

EBIT can be defined as earnings before interest and taxes.

Genmab EBIT 2019-2024 | GMAB

  • Genmab 2023 EBIT was 0.773B, a 14.17% decline from 2022.
  • Genmab 2022 EBIT was 0.9B, a 87.47% increase from 2021.
  • Genmab 2021 EBIT was 0.48B, a 50.35% decline from 2020.

EBIT can be defined as earnings before interest and taxes.